ARRB1 and lung carcinoma: Interestingly, we observed that a positive correlation exists between ARRB1 and most MHC molecules in LUSC, while the opposite is true in LUAD, suggesting that the immunomodulatory effects of ARRB1 differ according to the lung cancer type.